Presentation
13 March 2024 Detection of atherosclerotic plaques with nanoparticles as contrast agent using a multimodal imaging system
Author Affiliations +
Abstract
Atherosclerosis is a leading cause of global mortality. Current clinically available imaging techniques suffer from limited spatial resolution and lack the ability to identify biomolecular features of atherosclerotic plaques. To address this, our team has developed a bimodal imaging system which consists of optical coherence tomography (OCT) and fluorescence. In addition, a nanoparticle named porphysomes is used as a fluorescence contrast agent to target macrophages in the plaques of diseased mice. Results suggest that our intravascular imaging system is capable of detecting the fluorescence from nanoparticles which provides complementary biological information to the structural information obtained from simultaneously-acquired OCT images.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Rouyan Chen, Lauren Sandeman, Victoria Nankivell, Joanne T. M. Tan, Gang Zheng, Peter J. Psaltis, Christina Bursill, Robert A. McLaughlin, and Jiawen Li "Detection of atherosclerotic plaques with nanoparticles as contrast agent using a multimodal imaging system", Proc. SPIE 12819, Diagnostic and Therapeutic Applications of Light in Cardiology 2024, 128190A (13 March 2024); https://doi.org/10.1117/12.3000277
Advertisement
Advertisement
KEYWORDS
Imaging systems

Atherosclerosis

Fluorescence

Nanoparticles

Optical coherence tomography

Contrast agents

Multimodal imaging

Back to Top